Study on clinical profile of scabies and comparison of efficacy of topical agents in treatment of scabies

Rajalakshmi R; Karthikeyan Selvaraj

doi:10.18231/j.joapr.2023.11.5.59.63

Authors

Rajalakshmi R Department of Dermatology, ESIC Medical College and Hospital, Chennai, Tamil Nadu
Karthikeyan Selvaraj Department of General Surgery, Sree Balaji Medical College & Hospital, Chennai, Tamil Nadu

DOI:

https://doi.org/10.18231/j.joapr.2023.11.5.59.63

Keywords:

GBHC, Ivermectin, Permethrin, Scabies

Abstract

Background: Scabies is an intensely pruritic mite infestation. It is a significant health problem in developing countries and remains a major issue despite available treatment modalities. Methodology: A prospective study was carried out over a year with 90 scabies patients at a tertiary care center after obtaining Ethical Clearance to study the clinical profile of scabies, compare the efficacy of various topical scabicidal agents, and evaluate improvement after treatment. After calculating the severity of pruritus and lesions, a detailed history was noted and randomly allotted to one of the treatment groups. Group A was treated with 1% GBHC lotion, Group B with 5% Permethrin cream, and Group C with 0.5% Ivermectin cream. Patients were advised to review in the second, third, and sixth weeks. Observation and results: Patients with 16-25 years of age were most susceptible. 17 out of 90 patients had secondary bacterial infections, the most common associated cutaneous disease followed by dermatophytosis. Statistically significant reduction in pruritis severity in the drug C vs drug A trial (Z = -4.810, p = <0.001) and Drug C vs drug B trial (Z= -4.795, p= <0.001). Group C (Ivermectin) causes much better improvement in itching and lesions than Group A (GBHC) and Group B (Permethrin). Conclusion: Among topicals, ivermectin can be preferred over permethrin and GBHC for treating scabies. Topical permethrin provides superior improvement when juxtaposed to GBHC and can be considered better than GBHC.

Downloads

Download data is not yet available.

References

Hafedh AH, Al-Hilo MM, Jassem MS. Ivermectin versus topical sulfur in treatment of scabies: an open therapeutic trial. Journal of Applied Medical Sciences 2(3), 67-79 (2013)

Sharma R, Singal A. Topical permethrin and oral ivermectin in the management of scabies: a prospective, randomized, double blind, controlled study. Indian J Dermatol Venereol Leprol 77, 581-6 (2011)

Engelman D, Cantey PT, Marks M, Solomon AW, Chang AY, Chosidow O et al. The public health control of scabies: priorities for research and action. Lancet 394, 81-92 (2019)

Welch E, Romani L, Whitfeld MJ. Recent advances in understanding and treating scabies. Fac Rev 10, 28 (2021)

World Health Organization: Scabies and other ectoparasites. 2020.

Heukelbach J, Wilcke T, Winter B, Feldmeier H. Epidemiology and morbidity of scabies and pediculosis capitis in resource-poor communities in Brazil. Br J Dermatol 153, 150-6 (2005)

Bernigaud C, Fischer K, Chosidow O. The Management of Scabies in the 21st Century: Past, Advances and Potentials. Acta Derm Venereol 100, adv00112 (2020)

Romani L, Whitfeld MJ, Koroivueta J, Kama M, Wand H, Tikoduadua L et al. The Epidemiology of Scabies and Impetigo in Relation to Demographic and Residential Characteristics: Baseline Findings from the Skin Health Intervention Fiji Trial. Am J Trop Med Hyg 97, 845-50 (2017)

Lynar S, Currie BJ, Baird R. Scabies and mortality. Lancet Infect Dis 17, 1234 (2017)

Verma S, Ahsan M, Singh HK, Rathore PK. An interventional study to evaluate the efficacy of topical ivermectin in the management of uncomplicated scabies. International Journal of Contemporary Medical Research 5(2), B5-B8 (2018)

Goldust M, Rezaee E, Raghiafar R. Topical ivermectin versus crotamiton cream 10% for the treatment of scabies. Int J Dermatol 53, 904-8 (2014)

Meinking TL, Taplin D, Hermida JL, Pardo R, Kerdel FA. The treatment of scabies with ivermectin. N Engl J Med 333, 26-30 (1995)

Schultz MW, Gomez M, Hansen RC, Mills J, Menter A, Rodgers H et al. Comparative study of 5% permethrin cream and 1% lindane lotion for the treatment of scabies. Arch Dermatol 126, 167-70 (1990)